arrow
X

Xavier Mariette

Université Paris Saclay
H指数:110
被引数:5.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characteristics of patients with isolated anti-Ku antibodies

孤立性抗Ku抗体患者的特征

2026-10-230
PRE
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study

利用数字化唾液腺活检进行机器学习,以分类焦点评分和Sjögren's disease:一项回顾性队列研究

2025-09-290
PRE
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

早期类风湿关节炎患者中1个月甲氨蝶呤延迟对肺炎球菌疫苗免疫原性和疾病控制的影响(VACIMRA):一项开放标签随机试验

2025-07-290
PRE
2023 International Rome consensus for the nomenclature of Sjögren disease

关于舍格伦病命名的2023国际罗马共识

2025-06-100
PREAI
Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study

边缘区淋巴瘤的治疗方式与总生存期,血液学反应和潜在的干燥症活动: 一项多中心,回顾性,观察性研究

2024-10-011
PRE
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
LANCET
IF88.5
2024-08-013
PRE
SAFETY AND EFFICACY OF ISCALIMAB IN PATIENTS WITH SJÖGREN'S DISEASE: 48-WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL

ISCALIMAB在舍格伦综合征患者中的安全性与有效性:一项随机、安慰剂对照、剂量范围IIb期试验的48周结果

2024-06-010
PRE
ASSESSMENT OF S95011 (OSE-127, LUSVERTIKIMAB), AN ANTI-INTERLEUKIN 7 RECEPTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME: AN INTERNATIONAL MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PHASE 2A STUDY

评估S95011(OSE-127,LUSVERTIKIMAB),一种抗白介素7受体单克隆抗体,在原发性舍格伦综合征患者中的研究:一项国际多中心、随机、双盲、安慰剂对照、2A期研究

2024-06-010
PRE
Identification of distinct subgroups of Sjogren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

通过基于临床和生物学表现的聚类分析识别干燥症的不同亚组: 来自横断面paris-saclay和前瞻性评估队列的数据

2024-04-019
OAAI
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
2024-03-012
OAAI